A Flexible-Dose Titration Study of Aptensio XR in Children Ages 4 to Under 6 Years Diagnosed With ADHD

Clinical trial NCT02683265 · COMPLETED

Trial details

NCT number: NCT02683265
Sponsor: Rhodes Pharmaceuticals, L.P.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Attention Deficit Disorder With Hyperactivity

Start date: 2016-04-25
Primary completion: 2017-11-02
Enrollment: 158

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.